Terns Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.

About TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. 

CEO
Senthil Sundaram
CEOSenthil Sundaram
Employees
41
Employees41
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2017
Founded2017
Employees
41
Employees41

TERN Key Statistics

Market cap
226.81M
Market cap226.81M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
218.90K
Average volume218.90K
High today
$6.14
High today$6.14
Low today
$5.66
Low today$5.66
Open price
$5.90
Open price$5.90
Volume
28.69K
Volume28.69K
52 Week high
$7.92
52 Week high$7.92
52 Week low
$1.45
52 Week low$1.45

TERN Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 2, After Hours
ActualExpected Mar 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.